IMOVAX POLIO
Description
Imovax Polio is an Inactivated Poliomyelitis Vaccine containing 3 Types of Polioviruses which cause Polio.
IMMUNIZATION GUIDELINE
Primary vaccination:
- From 2 months of age, 3 successive injections of 0.5 ml should be administered at intervals of one or two months
- From 6 weeks of age, IMOVAX POLIO may be administered following the 6, 10, 14-week schedule, as per the recommendations of the Expanded Programme on Immunisation of the World Health Organisation.
Booster:
- In children in the second year of life, a 4th dose (1st booster) is administered one year after the 3rd injection. A booster is given every 5 years in children
For latest IAP updates see revised immunization schedule.
Additional information
vaccine-type | Polio vaccine – injectable |
---|---|
manufacturer | Sanofi Pasteur |
country-of-manufacture | France |
pharmaceutical-form | Liquid |
package-size | 10 Dose |
route-of-administration | Intramuscular, Subcutaneous |
preservative | Phenoxyethanol, |
Contraindications | Do not use IMOVAX POLIO if your child is allergic to the active substances, to one of the excipients, to neomycin, to streptomycin or to polymyxine B or have had an allergic reaction following a previous injection of this vaccine. Have a fever or acute illness; in this case, vaccination should be postponed. |